Related Experiment Video
Updated: Jul 22, 2026
11:12
Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects
Published on: September 18, 2012
Simulated car crashes at intersections in drivers with Alzheimer disease
M Rizzo1, D V McGehee, J D Dawson
1College of Medicine, University of Iowa, Iowa City, USA. matthew-rizzo@uiowa.edu
Alzheimer Disease and Associated Disorders
|March 10, 2001
Summary
Drivers with Alzheimer disease (AD) are at higher risk for intersection crashes due to cognitive impairments affecting attention and reaction time. Simulation results show impaired drivers struggle to avoid unexpected vehicles, highlighting the need for driving fitness assessments.
Area of Science:
- Neuroscience
- Gerontology
- Traffic Safety
Background:
- Cognitively impaired older drivers are prone to car crashes, particularly at intersections.
- Failure to notice other vehicles is a common cause of these accidents.
Purpose of the Study:
- To investigate if drivers with mild to moderate Alzheimer disease (AD) face increased risks of intersection crashes.
- To identify cognitive predictors of crash risk in individuals with AD.
Main Methods:
- A driving simulator study involving 30 participants (18 with AD, 12 controls) approaching intersections with sudden vehicle incursions.
- Analysis of steering, braking, acceleration, and speed data during critical timeframes before simulated crashes.
Main Results:
- 33% of drivers with AD (6 of 18) crashed in the simulation, compared to 0% of controls.
- Crash events were associated with inattention and delayed/inappropriate vehicle control responses.
- Visuospatial impairment, attention deficits, and reduced visual motion processing predicted crashes.
Conclusions:
- Mild to moderate Alzheimer disease significantly increases intersection crash risk.
- Cognitive declines in specific domains are directly linked to driving impairment in AD.
- High-fidelity simulation and neuropsychological testing are valuable for assessing driving fitness in medically impaired individuals.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...